Generate Investment Management Ltd
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2025905
AUCKLAND, Q2
Position in REGN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$14,341,420
+$10,549,303 QoQ
Shares Held
23,000
+368.6% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
#245
of 1,322 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Generate Investment Management Ltd holds $15,122,776 across 2 Biotechnology names. REGN ranks #1 (94.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
23,000 | $14,341,420 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,573 | $781,356 |
All Filings in REGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,341,420 | 23,000 | Shares | Other | 2026-07-27 | |
| 2026-03-31 | $3,792,117 | 4,908 | Shares | Sole | 2026-04-16 | |
| 2025-09-30 | $10,558,306 | 18,778 | Shares | Other | 2025-10-20 | |
| 2025-06-30 | $6,300,000 | 12,000 | Shares | Other | 2025-07-17 | |
| 2024-12-31 | $5,585,379 | 7,841 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $11,315,547 | 10,764 | Shares | Sole | 2024-10-18 | |
| 2024-03-31 | $6,453,495 | 6,705 | Shares | Sole | 2024-08-01 | |
| No filing history on record for this holder in this stock. | ||||||